Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 23,735 | 20,591 | 20,450 | 21,774 | 24,556 |
| Cost of Goods | 9,563 | 8,570 | 8,917 | 9,590 | 10,545 |
| Gross Profit | 14,172 | 12,021 | 11,533 | 12,184 | 14,011 |
| Operating Expenses | 13,025 | 12,394 | 13,269 | 62,442 | 14,545 |
| Operating Income | 1,710 | 197 | -819 | -49,668 | 11 |
| Interest Expense | 2,358 | 966 | 791 | 802 | 1,180 |
| Other Income | -2,556 | -365 | -644 | -324 | 1,759 |
| Pre-tax Income | -3,204 | -1,134 | -2,254 | -50,794 | 590 |
| Income Tax | -357 | 97 | 28 | -454 | 572 |
| Net Income Continuous | -2,847 | -1,231 | -2,282 | -50,340 | 18 |
| Net Income | $-2,847 | $-1,231 | $-2,282 | $-50,340 | $18 |
| EPS Basic Total Ops | -0.60 | -0.30 | -0.50 | -11.40 | 0.10 |
| EPS Basic Continuous Ops | -0.57 | -0.28 | -0.52 | -11.42 | 0.01 |
| EPS Diluted Total Ops | -0.60 | -0.30 | -0.50 | -11.40 | 0.10 |
| EPS Diluted Continuous Ops | -0.57 | -0.28 | -0.52 | -11.42 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.10 | -0.20 | -0.20 | 0.40 |
| EBITDA(a) | $3,684 | $1,878 | $1,007 | $69 | $1,869 |